Some perspective of earned revenue and estimates,
JunQ21 Revenue was 2.6m USD (included one off licence deals)
SepQ21 Revenue was 1.9m USD (run rate comparable to acquired NZ Wirecard business)
CCA has been investing in itself and is on track. If the growth happens, looking for revenue of;
DecQ21 Revenue - above 2.5m USD (Upgrades & some new PaySim clients)
MarQ22 Revenue - above 2.5m USD (steady)
JunQ22 Revenue - above 3.0m USD (Vertexon income cranks up as onboarding new card programs take effect)
Building the revenue and accelerating into FY23.
- Forums
- ASX - By Stock
- CCA
- Ann: Quarterly update & Appendix 4C
CCA
change financial limited
Add to My Watchlist
0.00%
!
6.8¢

Ann: Quarterly update & Appendix 4C, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.70M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 45484 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 9802 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 45484 | 0.069 |
1 | 250000 | 0.068 |
1 | 4000 | 0.067 |
3 | 258000 | 0.065 |
2 | 156451 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 9802 | 2 |
0.072 | 13000 | 2 |
0.073 | 573042 | 1 |
0.074 | 130000 | 2 |
0.075 | 200000 | 1 |
Last trade - 10.30am 04/07/2025 (20 minute delay) ? |
Featured News
CCA (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online